M0 (N=1312) | M1A (N=373) | M1S (N=651) | Overall (N=2336) | |
Year of first achieving stability of PDR (R3S) | ||||
2015 | 364 (27.7%) | 78 (20.9%) | 148 (22.7%) | 590 (25.3%) |
2016 | 253 (19.3%) | 83 (22.3%) | 138 (21.2%) | 474 (20.3%) |
2017 | 222 (16.9%) | 78 (20.9%) | 125 (19.2%) | 425 (18.2%) |
2018 | 249 (19.0%) | 76 (20.4%) | 126 (19.4%) | 451 (19.3%) |
2019 | 224 (17.1%) | 58 (15.5%) | 114 (17.5%) | 396 (17.0%) |
Gender | ||||
Female | 533 (40.6%) | 140 (37.5%) | 257 (39.5%) | 930 (39.8%) |
Male | 779 (59.4%) | 233 (62.5%) | 394 (60.5%) | 1406 (60.2%) |
Age | ||||
Mean (SD) | 59.0 (14.5) | 59.7 (13.1) | 59.8 (13.2) | 59.3 (13.9) |
Median (min, max) | 59.8 (21.0, 90.8) | 60.1 (25.6, 91.8) | 60.3 (22.7, 87.6) | 60.1 (21.0, 91.8) |
Ethnicity | ||||
Caucasian | 333 (25.4%) | 99 (26.5%) | 138 (21.2%) | 570 (24.4%) |
Afro Caribbean | 169 (12.9%) | 44 (11.8%) | 75 (11.5%) | 288 (12.3%) |
South Asian | 385 (29.3%) | 109 (29.2%) | 202 (31.0%) | 696 (29.8%) |
Chinese | 5 (0.4%) | 0 (0%) | 5 (0.8%) | 10 (0.4%) |
Mixed | 10 (0.8%) | 4 (1.1%) | 7 (1.1%) | 21 (0.9%) |
Unknown | 410 (31.2%) | 117 (31.4%) | 224 (34.4%) | 751 (32.1%) |
Baseline demography characteristic shown for cohort at baseline that is, first recording of stable proliferative diabetes following panretinal photocoagulation. Data shown for entire cohort (overall), as well as stratified by macular status: absence of diabetic macular oedema (DME; M0), active DME on treatment (M1A) or stable DME under observation (M1S). Mean, SD, median, minimum and maximum values are shown for age in years. Proportions in percentages shown for gender, ethnicity and year of first record of stability.
PDR, proliferative diabetic retinopathy .